Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.

Autor: Eskelund CW; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Centre and.; Danish Stem Cell Center, University of Copenhagen, Copenhagen, Denmark., Husby S; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Centre and.; Danish Stem Cell Center, University of Copenhagen, Copenhagen, Denmark., Favero F; Biotech Research and Innovation Centre and.; Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark., Klausen TW; Hematological Research Laboratory, Herlev University Hospital, Herlev, Denmark., Rodriguez-Gonzalez FG; Biotech Research and Innovation Centre and.; Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark., Kolstad A; Department of Oncology, Oslo University Hospital, Oslo, Norway., Pedersen LB; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Räty RK; Department of Hematology, Helsinki University Hospital, Helsinki, Finland; and., Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Jerkeman M; Department of Oncology, Skåne University Hospital, Lund, Sweden., Weischenfeldt J; Biotech Research and Innovation Centre and.; Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark., Grønbæk K; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Centre and.; Danish Stem Cell Center, University of Copenhagen, Copenhagen, Denmark.
Jazyk: angličtina
Zdroj: Blood [Blood] 2020 May 28; Vol. 135 (22), pp. 2000-2004.
DOI: 10.1182/blood.2019003539
Databáze: MEDLINE